ClinicalTrials.gov
ClinicalTrials.gov Menu

The Men's Domestic Abuse Check-Up Engages Adult Men Concerned About Their Abusive Behavior and Alcohol or Drug Use (MDACU)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01621334
Recruitment Status : Completed
First Posted : June 18, 2012
Last Update Posted : June 18, 2012
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Lyungai Mbilinyi, University of Washington

Brief Summary:
This research is a stage 1b developmental trial evaluating an intervention called "The Men's Domestic Abuse Check-Up" with adult men abusing their intimate partners and also struggling with alcohol or drug use.

Condition or disease Intervention/treatment Phase
Domestic Violence Substance Abuse Behavioral: Motivational Enhancement Therapy Behavioral: Educational information Phase 1

Detailed Description:

One hundred and forty adult men concerned about their substance use and behaviors toward intimate partners, recruited in Washington State, will be enrolled in the trial. Participants are recruited through print and radio ads. Following a baseline assessment, participants are then randomly assigned to receive one of two interventions:

  • The experimental intervention is a two-session motivational enhancement treatment. A personalized feedback report, containing information from the participant's assessment as well as normative comparison data, is reviewed, with the counselor employing motivational interviewing strategies intended to impact study outcomes.
  • The comparison condition involves an educational brochure focusing on the legal, health and behavioral effects of intimate partner violence, substance abuse, and HIV risky behaviors.

Following the two interventions, participants are reassessed at 1 week, 1 month, and 4 months following either intervention.


Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 140 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Stage 1B Study Motivating Substance Abusing Batterers to Seek Treatment.
Study Start Date : September 2009
Actual Primary Completion Date : May 2012
Actual Study Completion Date : May 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Pet Health
U.S. FDA Resources

Arm Intervention/treatment
Experimental: Motivational Enhancement Therapy
Motivational Enhancement Therapy
Behavioral: Motivational Enhancement Therapy
Two personal feedback sessions with counselor using motivational interviewing strategies.
Educational brochure
Intimate Partner Violence, Substance Abuse, and HIV risky behaviors Education
Behavioral: Educational information
Educational brochure about legal, health and behavioral effects of intimate partner violence, substance abuse, and HIV risky behaviors



Primary Outcome Measures :
  1. treatment seeking [ Time Frame: 4 months ]

Secondary Outcome Measures :
  1. self-report of intimate partner violence and substance use [ Time Frame: 4 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • age (18 years and older)
  • gender (male)
  • self-reported abusive behaviors
  • concerned about alcohol or drug use

Exclusion Criteria:

  • not fluent in English
  • they have a thought disorder that precludes full participation
  • they refuse to accept randomization to condition

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01621334


Locations
United States, Washington
Innovative Programs Research Group, School of Social Work, University of Washington
Seattle, Washington, United States, 98105
Sponsors and Collaborators
University of Washington
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Lyungai F Mbilinyi, PhD University of Washington School of Social Work

Responsible Party: Lyungai Mbilinyi, Principal Investigator, University of Washington
ClinicalTrials.gov Identifier: NCT01621334     History of Changes
Other Study ID Numbers: 37863-C
R01DA017873 ( U.S. NIH Grant/Contract )
First Posted: June 18, 2012    Key Record Dates
Last Update Posted: June 18, 2012
Last Verified: June 2012

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders